Common use of Effect of Termination for Cause on License Clause in Contracts

Effect of Termination for Cause on License. (a) If either Merck or Company terminates this Agreement under Section 8.3.1(a) or Section 8.3.1(b), then Merck’s sublicense(s) and license(s) pursuant to Section 3.1 and Section 3.2 shall terminate as of such termination date and each Party shall, within thirty (30) days after the effective date of such termination, return or cause to be returned to the other Party all Information of the other Party in tangible form and substances or compositions delivered or provided by the other Party, as well as any other material provided by the other Party in any medium; provided, however, that each Party may retain one copy of Information received from the other Party in its confidential files for record purposes. 40

Appears in 3 contracts

Samples: Exclusive Patent License and Research Collaboration Agreement, Exclusive Patent License and Research (Cue Biopharma, Inc.), Exclusive Patent License and Research (Cue Biopharma, Inc.)

AutoNDA by SimpleDocs

Effect of Termination for Cause on License. (a) If either Merck or Company terminates this Agreement under Section 8.3.1(a) or Section 8.3.1(b), then Merck’s sublicense(s) and license(s) pursuant to Section 3.1 and Section 3.2 [***] shall terminate as of such termination date and each Party shall, within thirty (30) days after the effective date of such termination, return or cause to be returned to the other Party all Information of the other Party in tangible form and substances or compositions delivered or provided by the other Party, as well as any other material provided by the other Party in any medium; provided, however, that each Party may retain one copy of Information received from the other Party in its confidential files for record purposes. 40

Appears in 1 contract

Samples: Exclusive Patent License and Research Collaboration Agreement

AutoNDA by SimpleDocs

Effect of Termination for Cause on License. (a) If either Merck or Company terminates this Agreement under Section 8.3.1(a) or Section 8.3.1(b), then Merck’s sublicense(s) and license(s) pursuant to Section 3.1 and Section 3.2 [***] shall terminate as of such termination date and each Party shall, within thirty (30) days after the effective date of such termination, return or cause to be returned to the other Party all Information of the other Party in tangible form and substances or compositions delivered or provided by the other Party, as well as any other material provided by the other Party in any medium; provided, however, that each Party may retain one copy of Information received from the other Party in its confidential files for record purposes. 40.

Appears in 1 contract

Samples: Exclusive Patent License and Research (Cue Biopharma, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.